M Hussain
Applications of p53 interactome analysis to personalised drug discovery
Hussain, M; Stutchbury, B; Tian, K; Atalay, R; Schwartz, JM; Krstic-Demonacos, M
Authors
B Stutchbury
K Tian
R Atalay
JM Schwartz
Prof Marija Krstic-Demonacos M.Krstic-Demonacos@salford.ac.uk
Professor of Molecular Medicine
Abstract
The stress responsive transcription factor p53 is a powerful tumor suppressor implicated in over 50 % of all human cancers. The complexity and nonlinear dynamics of p53 network coupled with extensive literature is challenging. Sys-tems biology methodologies offer promising tools to investigate perturbed net-works, providing structured in silico representations for integrative analysis. The Boolean p53 interactome (PKT206) incorporates the diverse p53 information into a comprehensible framework, and demonstrated good predictive ratios (51 – 75%) using logical steady state analysis. Whilst extensive, Boolean models provide only a qualitative approximation of the system. A prerequisite of diseased in silico models is to accurately represent biological phenomena to characterize network perturbations for effective drug candidates. Thus a quanti-tative approach is necessitated. We have applied a novel signal transduction al-gorithm (STSFA) to PKT206 for model performance and comparison. The STSFA quantitatively analyses large scale ‘omics’ data, typically not accessible with large networks. STFSA in silico simulations of DNA damage and p53 knock out were accurately predicted compared to various gene expression pro-files (P = <1x10-16), and was consistently more accurate than LSSA, generating a significantly higher proportion of correct predictions (P = 0.003). Furthermore, genes CKS2, WWP1, EPHB4 were identified as prospective drug candidates by in silico knockout analysis. In summary, refinement of Boolean PKT206 using STFSA has provided a semi quantitative view of the p53 interactome, and along with the use of ‘omics’ data, may be of greater clinical relevance for identification of perturbed pathways and personalized therapies by superimposition of individual genomic profiles.
Citation
Hussain, M., Stutchbury, B., Tian, K., Atalay, R., Schwartz, J., & Krstic-Demonacos, M. (2014, April). Applications of p53 interactome analysis to personalised drug discovery. Presented at Conference: International Work-Conference on Bioinformatics and Biomedical Engineering (IWBBIO 2014), Universidad de Granada, Granada, Spain
Presentation Conference Type | Other |
---|---|
Conference Name | Conference: International Work-Conference on Bioinformatics and Biomedical Engineering (IWBBIO 2014) |
Conference Location | Universidad de Granada, Granada, Spain |
Start Date | Apr 7, 2014 |
End Date | Apr 9, 2014 |
Publication Date | Apr 7, 2014 |
Deposit Date | Mar 16, 2015 |
Additional Information | Event Type : Conference Projects : Graduate training studentship |
You might also like
Intratumor microbiota as a novel potential prognostic indicator in mesothelioma
(2023)
Journal Article
Elimination of Off-Target Effect by Chemical Modification of 5'-End of Small Interfering RNA
(2022)
Journal Article
Downloadable Citations
About USIR
Administrator e-mail: library-research@salford.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search